I have a patient who had a failed mesh placement and a panniculectomy and who has developed at least three separate fistulas with a very large amount of output (3-4 L/24 hrs). Any suggestions? I am using an Eakin wound management pouch hooked up to wall suction.
Company licenses technology based dressings for distribution in India
- Fri, 7/30/10 - 1:44pm
- 0 Comments
- 549 reads
Quick-Med Technologies Inc (Gainesville, FL) recently signed a Patent and Technology License Agreement with Viridis BioPharma Pvt Ltd. Under terms of the agreement, Viridis will manufacture, market, and sell gauze wound dressings in India that incorporate Quick-Med's proprietary Nimbus® antimicrobial technology.
The technology is a cutting-edge antimicrobial technology that has been custom designed for wound care and other medical applications. It is the only non-leaching antimicrobial dressing which, by design, poses no risk of bacteria developing resistance.
Viridis BioPharma Pvt. Ltd. commercializes products with therapeutic efficacy and growth potential in the Indian subcontinent and delivers a range of clinically proven products to enable people to live better and more active lives. Viridis currently manufactures and markets a number of medical devices for companies, manufactured under license for B. Braun, American BioTech Labs, and Bhabha Atomic Research Center (BARC). Quick-Med expects Nimbus to become an important technology in the $14 billion global wound care market, as wound care companies and healthcare professionals look for more effective and efficient ways to prevent infections and avoid cross-contamination. By reducing the number of times a wound must be dressed, bandages containing the technology will subsequently diminish the opportunities for infection and cross-contamination. Fewer dressing changes will also help decrease labor costs for wound care patients.
For more information, visit www.quickmedtech.com or www.viridisbiopharma.com.
